Legalising lower dosage cannabis products could 'ignite industry'

Legalising lower dosage cannabis products could 'ignite industry'
Mitch Cuevas, pharmaceutical director at Katikati based medicinal cannabis firm Eqalis, said NZ is 'missing out' on an obvious export opportunity. (Image: Eqalis)
Brent Melville
Easing restrictions on low-level cannabidiol (CBD) for over-the-counter sales could boost cannabis earnings fourfold, creating a $2 billion sector within the next eight years, a new report says.Dr Nick Marsh, an analyst and consultant with Next Corp, said regulatory reform allowing expanded use of low potency CBD for nutraceuticals and food products could ignite the industry’s earning power.In New Zealand, any strength CBD is scheduled as a restricted medicine under the Medicines Act and therefore must be prescribed by a medical professio...

More Health

F&P Healthcare: don’t mention the tariffs!
Markets

F&P Healthcare: don’t mention the tariffs!

Mexican and Chinese plants could face tariffs on exports to the US.

Pattrick Smellie 28 Nov 2024
Record half for F&P Healthcare
Markets

Record half for F&P Healthcare

A strong result boosts dividend, suspends dividend reinvestment scheme.

Pattrick Smellie 28 Nov 2024
Nanogirl liquidates Lab
Health

Nanogirl liquidates Lab

Nanogirl Labs liquidated as funding cuts hit STEM education.

Garth Bray 28 Nov 2024
Blis in the black
Markets

Blis in the black

Blis has reported an increase in revenue and earnings despite a patent dispute.

Staff reporters 26 Nov 2024